Amwill Health Care Limited (BOM:544353)
India · Delayed Price · Currency is INR 42.20
+1.65 (4.07%)
At close: Jan 22, 2026
Amwill Health Care Revenue
Amwill Health Care had revenue of 212.05M INR in the half year ending September 30, 2025. This brings the company's revenue in the last twelve months to 386.31M. In the fiscal year ending March 31, 2025, Amwill Health Care had annual revenue of 405.82M, down -7.66%.
Revenue (ttm)
386.31M
Revenue Growth
-7.66%
P/S Ratio
2.05
Revenue / Employee
4.39M
Employees
88
Market Cap
790.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 405.82M | -33.67M | -7.66% |
| Mar 31, 2024 | 439.48M | 137.82M | 45.69% |
| Mar 31, 2023 | 301.66M | 25.53M | 9.25% |
| Mar 31, 2022 | 276.13M | 96.14M | 53.41% |
| Mar 31, 2021 | 179.99M | 178.56M | 12,465.18% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mangalam Drugs & Organics | 2.38B |
| Zenith Drugs | 1.44B |
| Makers Laboratories | 1.31B |
| Godavari Drugs | 1.06B |
| Accretion Pharmaceuticals | 826.43M |
| Mercury Laboratories | 773.75M |
| Shelter Pharma | 598.96M |
| Source Natural Foods and Herbal Supplements | 555.64M |